Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSDT)

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,276
  • Shares Outstanding, K 2,311
  • Annual Sales, $ 660 K
  • Annual Income, $ -14,130 K
  • 60-Month Beta 0.76
  • Price/Sales 64.51
  • Price/Cash Flow N/A
  • Price/Book 6.92
Trade HSDT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -1.22
  • Number of Estimates 1
  • High Estimate -1.22
  • Low Estimate -1.22
  • Prior Year -5.24
  • Growth Rate Est. (year over year) +76.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.17 +33.33%
on 03/25/21
20.98 -16.30%
on 03/26/21
+3.38 (+23.84%)
since 03/12/21
3-Month
11.37 +54.44%
on 03/05/21
20.98 -16.30%
on 03/26/21
+2.15 (+13.95%)
since 01/14/21
52-Week
9.14 +92.23%
on 04/15/20
34.00 -48.35%
on 01/05/21
+8.11 (+85.82%)
since 04/14/20

Most Recent Stories

More News
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that first quarter of fiscal year 2021 financial...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS(TM) Device

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that its wholly owned subsidiary, Helius Medical,...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rd

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the Investor...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Sherrie Perkins, effective...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
LIVN : 81.37 (-0.83%)
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter and full year...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that fourth quarter and fiscal year 2020 financial...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today the closing of an underwritten public offering...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today announced the pricing of an underwritten public...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services' Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today provided comments in response to a press release issued...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards

The Company's Stock Will Continue to be Listed and Traded on The Nasdaq Stock Market

HSM-S.TO : 1.98 (-1.49%)
HSDT : 17.56 (+0.75%)
HSM.TO : 21.75 (-1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

3rd Resistance Point 19.32
2nd Resistance Point 18.61
1st Resistance Point 18.02
Last Price 17.56
1st Support Level 16.72
2nd Support Level 16.01
3rd Support Level 15.42

See More

52-Week High 34.00
Fibonacci 61.8% 24.50
Fibonacci 50% 21.57
Fibonacci 38.2% 18.63
Last Price 17.56
52-Week Low 9.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar